Initial experience with a practical hyperfractionated accelerated radiotherapy regimen
Arnold M. Herskovic, Colin G. Orton, Mahmoud Seyedsadr et al. · International Journal of Radiation Oncology*Biology*Physics · 1991
Cited by 27 works. doi:10.1016/0360-3016(91)90286-d
Authors
- Arnold M. Herskovic
- Colin G. Orton
- Mahmoud Seyedsadr
- Paul B. Lattin
- Michael Kraut
- Ihn Han
- Sue J. Han
- Khursid Ahmad
- Jennifer Holt
References
- Statistical Methods for Rates and Proportions
- Statistical Methods for Rates and Proportions.
- The linear-quadratic formula and progress in fractionated radiotherapy
- The hazard of accelerated tumor clonogen repopulation during radiotherapy
- The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy
- A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.
- Twice-a-day radiation therapy for cancer of the head and neck
- Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx
- The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: An interim report
- Potential for increasing the differential response between tumors and normal tissues: Can proliferation rate be used?